Surgery Partners, Inc.
SGRY
$24.05
-$0.11-0.46%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -104.52% | -25.00% | -1,140.00% | 79.59% | -125.93% |
| Total Depreciation and Amortization | 44.25% | 3.26% | 8.36% | 7.61% | 18.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.88% | 48.86% | -41.85% | 67.01% | 47.74% |
| Change in Net Operating Assets | -31.16% | 42.97% | 42.62% | -401.38% | 170.32% |
| Cash from Operations | -21.26% | 103.44% | -34.98% | -40.15% | 100.77% |
| Capital Expenditure | 24.91% | -28.10% | -6.06% | -4.76% | 26.74% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | 100.00% | -101.66% |
| Cash Acquisitions | 87.33% | -284.62% | -75.00% | -488.68% | -89.29% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.11% | 20.00% | -26.76% | -545.45% | 98.19% |
| Cash from Investing | 79.68% | -193.74% | -43.03% | -126.95% | 64.04% |
| Total Debt Issued | -84.73% | 472.94% | -72.78% | 661.25% | 776.42% |
| Total Debt Repaid | 84.18% | -610.15% | 82.83% | -825.93% | -384.62% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 31.83% | -47.04% | 21.62% | -37.40% | 14.32% |
| Cash from Financing | -103.85% | 498.11% | 171.08% | -118.63% | 58.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.67% | 364.49% | 73.32% | -168.43% | 186.05% |
